Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Typ-2-Diabetes und Adipositas Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Bladder Dysfunction Reports
Erschienen in: Current Bladder Dysfunction Reports 1/2015

01.03.2015 | Pelvic Pain (C Payne and J Potts, Section Editors)

Classic Interstitial Cystitis: Unrelated to BPS

verfasst von: Magnus Fall, Ralph Peeker

Erschienen in: Current Bladder Dysfunction Reports | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

When first recognized, more than one hundred years ago, the term interstitial cystitis (IC) was reserved for subjects with a special type of deep inflammation of the bladder wall. Later, the scope of IC widened, including all kinds of bladder pain syndromes (BPS), giving rise to a lot of confusion and difficulties in research as well as in clinical practice. Herein, recent progress in the understanding of the BPS/IC complex will be discussed, emphasizing the fact that the classic Hunner disease (BPS type 3C according to the European Society for the Study of Interstitial Cystitis (ESSIC) classification) is a well-defined condition that fulfills the requirements of the denomination interstitial cystitis. The paper will also discuss recent research on diagnostics, markers, genetics, and various types of remedies for classic IC. For the benefit of our patients, in BPS/IC, it is time for a final separation of the concepts BPS and IC. Classic IC is a well-defined entity with multiple unique characteristics, those characteristics having a potential for development of a specific rational, pharmacological, and surgical treatment algorithm if further investigated. BPS, on the other hand, seems to include a heterogenic composition of conditions calling for broad attempts to be more closely explored.
Literatur
1.
Skene AJC. Diseases of bladder and urethra in women. New York: Wm Wood; 1887. 167 p.
2.
Hunner GL. Elusive ulcer of the bladder: further notes on a rare type of bladder ulcer with report of 25 cases. Am J Obstet. 1918;78:374–95.
3.
Hand JR. Interstitial cystitis: report of 223 cases (204 women and 19 men). J Urol. 1949;61:291–310.PubMed
4.
Messing EM, Stamey TA. Interstitial cystitis: early diagnosis, pathology and treatment. Urology. 1978;12:381–92.PubMedCrossRef
5.
Fall M, Johansson SL, Aldenborg F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol. 1987;137:35–8.PubMed
6.
Peeker R, Fall M. Towards a precise definition of interstitial cystitis: further evidence of differences in classic and nonulcer disease. J Urol. 2002;167:2470–2.PubMedCrossRef
7.
Wein A, Hanno P, Gillenwater J. In: Staskin, Hanno, Wein, Krane, editors. Interstitial cystitis. London: Springer; 1990. p. 3–15.CrossRef
8.
Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases workshop on interstitial cystitis, National Institutes of Health, Bethesda, Maryland, August 28–29, 1987. J Urol. 1988;140(1):203–6
9.
Nordling J, Anjum F, Bade J, Bouchelouche K, Bouchelouche P, Cervigni M, et al. Primary evaluation of patients suspected of having interstitial cystitis (IC). Eur Urol. 2004;45(5):662–9.PubMedCrossRef
10.••
van de Merwe JP, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha LK, et al. Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2008;53(1):60–7. A fundamental step taken by the ESSIC to correctly describe and classify investigations of BPS/IC patients.PubMedCrossRef
11.
Oravisto KJ. Epidemiology of interstitial cystitis. Ann Chir Gynaecol Finn. 1975;64:75–7.
12.
Koziol JA. Epidemiology of interstitial cystitis. Urol Clin N Am. 1994;21(1):7–20.
13.
Held PJ, Hanno PM, Wein AJ, Pauly MV, Cann MA. Epidemiology of interstitial cystitis 2. In: Staskin, Hanno, Wein, Krane, editors. Interstitial cystitis. New York: Springer; 1990. p. 29–48.CrossRef
14.
Curhan GC, Speizer FE, Hunter DJ, Curhan SG, Stampfer MJ. Epidemiology of interstitial cystitis: a population based study. J Urol. 1999;161:549–52.PubMedCrossRef
15.
Berry S, Elliott M, Suttorp M, Bogart L, Stoto M, Eggers P, et al. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the United States. J Urol. 2011;186(2):540–4.PubMedCentralPubMedCrossRef
16.
Suskind A, Berry S, Ewing B, Elliott M, Suttorp M, Clemens J. The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study. J Urol. 2013;189(1):141–5.PubMedCentralPubMedCrossRef
17.
Leppilahti M, Sairanen J, Tammela TL, Aaltomaa S, Lehtoranta K, Auvinen A, et al. Prevalence of clinically confirmed interstitial cystitis in women: a population based study in Finland. J Urol. 2005;174(2):581–3.PubMedCrossRef
18.
Erickson D, Tomaszewski J, Kunselman A, Bentley C, Peters K, Rovner E, et al. Do the National Institute of Diabetes and Digestive and Kidney Diseases cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol. 2005;173(1):93–7.PubMedCrossRef
19.•
Logadottir Y, Fall M, Kåbjörn-Gustafsson C, Peeker R. Clinical characteristics differ considerably between phenotypes of bladder pain syndrome/interstitial cystitis. Scand J Urol Nephrol. 2012;46(5):365–70. A paper demonstrating that a precise subtyping of BPS/IC can be achieved by adopting a rigorous investigation routine.PubMedCrossRef
20.
Meares Jr E. Interstitial cystitis—1987. Urology. 1987;29(4 Suppl):46–8.PubMed
21.
Webster GD, Galloway N. Surgical treatment of interstitial cystitis. Indications, techniques, and results. Urology. 1987;29(4 Suppl):34–9.PubMed
22.
O’Leary M, Sant G, Fowler FJ, Whitmore K, Spolarich-Kroll J. The interstitial cystitis symptom index and problem index. Urology. 1997;49(5A Suppl):58–63.PubMedCrossRef
23.
Rais-Bahrami S, Friedlander J, Herati A, Sadek M, Ruzimovsky M, Moldwin R. Symptom profile variability of interstitial cystitis/painful bladder syndrome by age. BJU Int 2012;109 (9).
24.
Lamale L, Lutgendorf S, Hoffman A, Kreder K. Symptoms and cystoscopic findings in patients with untreated interstitial cystitis. Urology. 2006;67(2):242–5.PubMedCrossRef
25.
Boudry G, Labat J, Normand L, Manunta A, Bensalah K, Rigaud J. Validation of voiding diary for stratification of bladder pain syndrome according to the presence/absence of cystoscopic abnormalities: a two-centre prospective study. BJU Int. 2013;112(2):E164–8.PubMedCrossRef
26.
Stav K, Lang E, Fanus Z, Leibovici D. Autonomic response during bladder hydrodistention in patients with bladder pain syndrome. J Urol. 2012;188(1):117–21.PubMedCrossRef
27.
Nickel J, Tripp D, Group. IICS. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome (IC/BPS). J Urol. 2014 Aug 1. pii: S0022-5347(14)04148-2.
28.
Killinger K, Boura J, Peters K. Pain in interstitial cystitis/bladder pain syndrome: do characteristics differ in ulcerative and non-ulcerative subtypes? Int Urogynecol J. 2013;24(8):1295–301.PubMedCrossRef
29.•
Ueda T, Nakagawa M, Okamura M, Tanoue H, Yoshida H, Yoshimura N. New cystoscopic diagnosis for interstitial cystitis/painful bladder syndrome using narrow-band imaging system. Int J Urol. 2008;15(12):1039–43. A promising technique to improve the diagnostic accuracy of cystoscopy.PubMedCrossRef
30.
Messing EM. The diagnosis of interstitial cystitis. Urology. 1987;29(4 Suppl):4–7.PubMed
31.
Furuya R, Masumori N, Furuya S, Oda T, Takahashi S, Takeuchi M. Glomerulation observed during transurethral resection of the prostate for patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia is a common finding but no predictor of clinical outcome. Urology. 2007;70(5):922–6.PubMedCrossRef
32.
Waxman J, Sulak P, Kuehl T. Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol. 1998;160(5):1663–7.PubMedCrossRef
33.
Richter B, Hesse U, Hansen A, Horn T, Mortensen S, Nordling J. Bladder pain syndrome/interstitial cystitis in a Danish population: a study using the 2008 criteria of the European Society for the Study of Interstitial Cystitis. BJU Int. 2010;105(5):660–7.PubMedCrossRef
34.••
Johansson SL, Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J Urol. 1990;143(6):1118–24. The first comprehensive outline on histopathological characteristics of classic IC.PubMed
35.
Tissot W, Diokno A, Peters K. A referral center’s experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol. 2004;172(2):478–80.PubMedCrossRef
36.
Erickson DR, Simon LJ, Belchis DA. Relationships between bladder inflammation and other clinical features in interstitial cystitis. Urology. 1994;44(5):655–9.PubMedCrossRef
37.
Fall M, Johansson SL, Vahlne A. A clinicopathological and virological study of interstitial cystitis. J Urol. 1985;133(5):771–3.PubMed
38.
Aldenborg F, Fall M, Enerbäck L. Proliferation and transepithelial migration of mucosal mast cells in interstitial cystitis. Immunology. 1986;58:411–6.PubMedCentralPubMed
39.
Irani A-MA, Bradford TR, Kepley CL, Schechter NM, Schwartz LB. Detection of MCT and MCTC types of human mast cells by immunohistochemistry using new monoclonal anti-tryptase and anti-chymase antibodies. J Histochem Cytochem. 1989;37:1509–15.PubMedCrossRef
40.
Peeker R, Fall M, Enerbäck L, Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J Urol. 2000;163:1009–15.PubMedCrossRef
41.
Leiby B, Landis J, Propert K, Tomaszewski J, Group. ICDBS. Discovery of morphological subgroups that correlate with severity of symptoms in interstitial cystitis: a proposed biopsy classification system. J Urol. 2007;177(1):142–8.PubMedCrossRef
42.
Kåbjörn-Gustafsson C, Peeker R. Biopsy retrieval, tissue handling, morphology and histopathological characteristics. In: Bladder pain syndrome. A guide for clinicians. Ed:s Nordling, Wyndaele, van de Merwe, Bouchelouche, Cervigni, Fall 2013; Springer Verlag: 231–9.
43.
Schwalenberg T, Stolzenburg J, Ho T, Mallock T, Hartenstein S, Alexander H, et al. Enhanced urothelial expression of human chorionic gonadotropin beta (hCGβ) in bladder pain syndrome/interstitial cystitis (BPS/IC). World J Urol. 2012;30(3):411–7.PubMedCrossRef
44.
Larsen M, Mortensen S, Nordling J, Horn T. Quantifying mast cells in bladder pain syndrome by immunohistochemical analysis. BJU Int. 2008;102:204–7.PubMedCrossRef
45.
Theoharides T, Kempuraj D, Tagen M, Conti P, Kalogeromitros D. Differential release of mast cell mediators and the pathogenesis of inflammation. Immunol Rev. 2007;217:65–78.PubMedCrossRef
46.
Erickson D, Tomaszewski J, Kunselman A, Stetter C, Peters K, Rovner E, et al. Urine markers do not predict biopsy findings or presence of bladder ulcers in interstitial cystitis/painful bladder syndrome. J Urol. 2008;179(5):1850–6.PubMedCentralPubMedCrossRef
47.••
Logadottir Y, Ehren I, Fall M, Wiklund NP, Peeker R. Intravesical nitric oxide production discriminates between classic and nonulcer interstitial cystitis. J Urol. 2004;171:1148–51. The first report presenting a marker (intraluminal evaporation of nitric oxide) that clearly can discriminate classic IC from non-Hunner BPS.PubMedCrossRef
48.
Koskela L, Thiel T, Ehren I, De Verdier P, Wiklund N. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.PubMedCrossRef
49.
Logadottir Y, Delbro D, Fall M, Gjertsson I, Jirholt P, Lindholm C, et al. Cytokine expression in patients with bladder pain syndrome/interstitial cystitis ESSIC type 3C. J Urol 2014; pii: S0022-5347(14)03518-6.
50.
Logadottir Y, Hallsberg L, Fall M, Peeker R, Delbro D. Bladder pain syndrome/interstitial cystitis ESSIC type 3C: high expression of inducible nitric oxide synthase in inflammatory cells. Scand J Urol Nephrol. 2013;47(1):52–6.CrossRef
51.
52.
Warren JW, Keay SK, Meyers D, Xu J. Concordance of interstitial cystitis in monozygotic and dizygotic twin pairs. Urology. 2001;57(6 Suppl 1):22–5.PubMedCrossRef
53.
Altman D, Lundholm C, Milsom I, Peeker R, Fall M, Iliadou AN, et al. The genetic and environmental contribution to the occurrence of bladder pain syndrome: an empirical approach in a nationwide population sample. Eur Urol. 2011;59(2):280–5.PubMedCrossRef
54.
Tseng L, Chen I, Wang C, Lin Y, Lloyd L, Lee C. Genome-based expression profiling study of Hunner’s ulcer type interstitial cystitis: an array of 40-gene model. Int Urogynecol J. 2010;21(8):911–8.PubMedCrossRef
55.
Blalock E, Korrect G, Stromberg A, Erickson D. Gene expression analysis of urine sediment: evaluation for potential noninvasive markers of interstitial cystitis/bladder pain syndrome. J Urol. 2012;187(2):725–32.PubMedCrossRef
56.
Fall M. Conservative management of chronic interstitial cystitis: transcutaneous electrical nerve stimulation and transurethral resection. J Urol. 1985;133:774–8.PubMed
57.
Peeker R, Aldenborg F, Fall M. Complete transurethral resection of ulcers in classic interstitial cystitis. Int Urogynecol J. 2000;11:290–5.CrossRef
58.
Shanberg AM, Malloy T. Treatment of interstitial cystitis with neodymium:YAG laser. Urology. 1987;29(4 Suppl):31–3.PubMed
59.
Hillelsohn J, Rais-Bahrami S, Friedlander J, Okhunov Z, Kashan M, Rosen L, et al. Fulguration for Hunner ulcers: long-term clinical outcomes. J Urol. 2012;188(6):2238–41.PubMedCrossRef
60.
Cox M, Klutke J, Klutke C. Assessment of patient outcomes following submucosal injection of triamcinolone for treatment of Hunner’s ulcer subtype interstitial cystitis. Can J Urol. 2009;16(2):4536–40.PubMed
61.
Sairanen J, Tammela TL, Leppilahti M, Multanen M, Paananen I, Lehtoranta K, et al. Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol. 2005;174(6):2235–8.PubMedCrossRef
62.
Forrest J, Payne C, Erickson D. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers. J Urol. 2012;188(4):1186–91.PubMedCrossRef
63.
Ehrén I, Hallén Grufman K, Vrba M, Sundelin R, Lafolie P. Nitric oxide as a marker for evaluation of treatment effect of cyclosporine A in patients with bladder pain syndrome/interstitial cystitis type 3C. Scand J Urol. 2013;47(6):503–8.PubMedCrossRef
64.
Fall M, Lindstrom S. Transcutaneous electrical nerve stimulation in classic and nonulcer interstitial cystitis. Urol Clin N Am. 1994;21(1):131–9.
65.
Fritjofsson A, Fall M, Juhlin R, Persson BE, Ruutu M. Treatment of ulcer and nonulcer interstitial cystitis with sodium pentosanpolysulfate: a multicenter trial. J Urol. 1987;138(3):508–12.PubMed
66.
Peeker R, Aldenborg F, Fall M. The treatment of interstitial cystitis with supratrigonal cystectomy and ileocystoplasty: difference in outcome between classic and nonulcer disease. J Urol. 1998;159(5):1479–82.PubMedCrossRef
67.
Rössberger J, Fall M, Jonsson O, Peeker R. Long-term results of reconstructive surgery in patients with bladder pain syndrome/interstitial cystitis: subtyping is imperative. Urology. 2007;70(4):638–42.PubMedCrossRef
68.
Peters K, Jaeger C, Killinger K, Rosenberg B, Boura J. Cystectomy for ulcerative interstitial cystitis: sequelae and patients’ perceptions of improvement. Urology. 2013;82(4):829–33.PubMedCrossRef
69.
Pinto R, Lopes T, Costa D, Barros S, Silva J, Silva C, et al. Ulcerative and nonulcerative forms of bladder pain syndrome/interstitial cystitis do not differ in symptom intensity or response to onabotulinum toxin A. Urology. 2014;83(5):1030–4.PubMedCrossRef
70.
Fall M, Logadottir Y, Peeker R. Interstitial cystitis is bladder pain syndrome with Hunner’s lesion. Int J Urol. 2014;21 Suppl 1:79–82.PubMedCrossRef
Metadaten
Titel
Classic Interstitial Cystitis: Unrelated to BPS
verfasst von
Magnus Fall
Ralph Peeker
Publikationsdatum
01.03.2015
Verlag
Springer US
Erschienen in
Current Bladder Dysfunction Reports / Ausgabe 1/2015
Print ISSN: 1931-7212
Elektronische ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-014-0273-4

Weitere Artikel der Ausgabe 1/2015

Current Bladder Dysfunction Reports 1/2015 Zur Ausgabe

Pelvic Pain (C Payne and J Potts, Section Editors)

Myofascial Pelvic Pain: Rationale and Treatment

Overactive Bladder (U Lee, Section Editor)

Evaluation and Treatment of Overactive Bladder after History of Cancer Treatment

Stress Incontinence and Prolapse (R Dmochowski, Section Editor)

How Best to Manage the Urethra at the Time of Prolapse Correction

Overactive Bladder (U Lee, Section Editor)

Complementary Alternative Medicine and Therapies for Overactive Bladder Symptoms: Is There Evidence for Benefit?

Stress Incontinence and Prolapse (R Dmochowski, Section Editor)

The Role of Mid-urethral Slings in 2014: Analysis of the Impact of Litigation on Practice

Overactive Bladder (U Lee, Section Editor)

Diet Modification for Overactive Bladder: an Evidence-Based Review

Neu im Fachgebiet Urologie

Viel pflanzliche Nahrung, seltener Prostata-Ca.-Progression

12.05.2024 Prostatakarzinom Nachrichten

Ein hoher Anteil pflanzlicher Nahrung trägt möglicherweise dazu bei, das Progressionsrisiko von Männern mit Prostatakarzinomen zu senken. In einer US-Studie war das Risiko bei ausgeprägter pflanzlicher Ernährung in etwa halbiert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise